ReviewEye (London, England)2011

Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: ranibizumab and bevacizumab.

C H Meyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.